is semaglutide or tirzepatide better vs. Semaglutide: Which for Weight loss? Tirzepatide vs. Semaglutide: What's the

The global Novo Phase 1b/2a readout in 2027 is the critical test of that extrapolation

Concomitant medications may also be relevant

have obesity, representing over 100 million patients

Key Takeaways Tirzepatide vs semaglutide comes down to dual agonist vs single agonist: tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1 alone The only head-to-head trial (SURPASS-2) found tirzepatide superior to semaglutide for both blood sugar control and weight loss In separate obesity trials, tirzepatide 15mg achieved 20.9% weight loss at 72 weeks vs semaglutide 2.4mg's 14.9% at 68 weeks Semaglutide has proven cardiovascular benefit (SELECT trial: 20% MACE reduction)

PET-CT reveals increased intestinal glucose uptake after gastric surgery